Loading...

Trump’s health secretary isn’t a fan of the ‘gold standard’ substance-use treatment — bad news for the opioid crisis

Loading...
Trump’s health secretary isn’t a fan of the ‘gold standard’ substance-use treatment — bad news for the opioid crisis - Apa khabar sahabat TIMES NEW MALAYSIA, Dalam artikel yang anda baca kali ini dengan tajuk Trump’s health secretary isn’t a fan of the ‘gold standard’ substance-use treatment — bad news for the opioid crisis, kami telah menyediakan dengan baik untuk artikel ini anda membaca dan memuat turun maklumat di dalamnya. mudah-mudahan mengisi jawatan Artikel BOLASEPAK, Artikel NEWS, Artikel PERNIAGAAN, kita menulis ini, anda boleh memahami. Nah, selamat membaca.

Tajuk : Trump’s health secretary isn’t a fan of the ‘gold standard’ substance-use treatment — bad news for the opioid crisis
link : Trump’s health secretary isn’t a fan of the ‘gold standard’ substance-use treatment — bad news for the opioid crisis

lihat juga


Trump’s health secretary isn’t a fan of the ‘gold standard’ substance-use treatment — bad news for the opioid crisis

tom price opioids maine lepage

AP Photo/Robert F. Bukaty

U.S. Secretary of Health and Human Services Tom Price, left, accompanied by Maine Gov. Paul LePage, speaks to reporters after a meeting to discuss the state’s efforts to fight the opioid epidemic, Wednesday, May 10, 2017, at the State House in Augusta, Maine.

US Health and Human Services Secretary Tom Price was visiting West Virginia on Tuesday for a “listening tour” to brainstorm solutions to the current opioid crisis when a reporter asked Price his thoughts on various drug treatment options, according to a report from the Charleston Gazette-Mail.

While Price echoed the Obama administration by calling substance-use disorder a “disease” and the crisis a “public health issue” and not a “criminal justice issue,” Price went against the prevailing wisdom on treatment options.

Price touted the success of faith-based treatment programs, and was decidedly non-supportive of medication-assisted treatment (MAT).

“If we’re just substituting one opioid for another, we’re not moving the dial much,” Price said of MAT, according to the Charleston Gazette-Mail. “Folks need to be cured so they can be productive members of society and realize their dreams.”

Considered by many experts to be the “gold standard” for overcoming opioid addiction, MAT uses prescription medications like buprenorphine or methadone to reduce cravings, allowing patients to work on the underlying issues leading to their substance use, without the constant pressure of withdrawal.

Studies in 2008 and 2011 conducted by the National Institute on Drug Abuse found that treatment using Suboxone, the most commonly prescribed version of buprenorphine, showed a “marked reduction” in drug use for participants. Approximately 50% of participants in the 2011 study reduced their substance use during extended Suboxone treatment. The success rate dropped to 8.6% once it was discontinued.

Because of its promising results, MAT has gained bipartisan support in statehouses, on Capitol Hill, and in scientific, medical, and treatment circles. But it’s expensive and remains difficult to access.

Bradley Stein, a senior natural scientist at the RAND Corporation who studies substance-use disorders, told Business Insider that MAT has “changed the landscape of treatment” for opioid-use disorder.

Stein said that states hit hard by the crisis like West Virginia and Pennsylvania have worked hard to expand access to MAT through public programs, Medicaid, and by expanding the number of physicians trained and certified to provide MAT.

West Virginia University is currently working to train primary care physicians throughout the state on how to administer medication-assisted treatment to expand desperately needed treatment across the state, Dr. Richard Vaglienti, the director of the Pain Management Center at West Virginia University told Business Insider earlier this year.

West Virginia had the highest drug-overdose death rate in the US with 41.5 deaths per 100,000 people in 2015.

Why Price’s opinion is important

suboxone heroin drugs

REUTERS/Brian Snyder

James Ingemi picks up Suboxone prescription as part of his treatment regimen for opiate dependency at the pharmacy at Boston Healthcare for the Homeless Program in Boston, Massachusetts January 14, 2013.

Secretary Price’s comments are extremely important because his opinions will shape the Trump administration’s approach to the opioid crisis.

With the American Health Care Act set to gut funding to Medicaid if passed, programs and policies implemented or championed by Price will take on increased relevance

During his last year in office, President Barack Obama signed two landmark laws — the Comprehensive Addiction and Recovery Act and the 21st Century Cares Act — that call for considerable funds for the opioid crisis. But how much and where those funds will go are hardly certain. Congress will continue to debate that in its budget negotiations.

It is not inconceivable to imagine Price recommending shifting funds allocated for MAT to faith-based treatments, if he thinks it is the best treatment option available.

Opioids, unlike many other substances, fundamentally change a person’s thought and behavior patterns.Almost all faith-based treatments are centered around achieving abstinence, but many addicts’ physical dependence on opioids makes abstinence incredibly difficult, if not impossible. Countless users relapse or skip out on treatment, no matter what stage of recovery they’re at.

MAT can be the difference between life or death for deeply entrenched opioid users, Turner Bitton, the president of the Drug Policy Project of Utah (DPP), told Business Insider. Those who fail out of abstinence-based treatment can go into a deep spiral of continuing use. Bitton is working to improve MAT access in Utah.

Trump established a commission headed by New Jersey Gov. Chris Christie in March to come up with solutions to the opioid crisis. The commission is set to submit a report by the end of the year.

NOW WATCH: Watch Sally Yates go toe to toe with Ted Cruz over Trump’s immigration ban

Please enable Javascript to watch this video

Read more stories on Business Insider, Malaysian edition of the world’s fastest-growing business and technology news website.



✍ Sumber Pautan : ☕ Business InsiderBusiness Insider

Kredit kepada pemilik laman asal dan sekira berminat untuk meneruskan bacaan sila klik link atau copy paste ke web server : http://ift.tt/2qsDfuh

(✿◠‿◠)✌ Mukah Pages : Pautan Viral Media Sensasi Tanpa Henti. Memuat-naik beraneka jenis artikel menarik setiap detik tanpa henti dari pelbagai sumber. Selamat membaca dan jangan lupa untuk 👍 Like & 💕 Share di media sosial anda!

tom price opioids maine lepage

AP Photo/Robert F. Bukaty

U.S. Secretary of Health and Human Services Tom Price, left, accompanied by Maine Gov. Paul LePage, speaks to reporters after a meeting to discuss the state’s efforts to fight the opioid epidemic, Wednesday, May 10, 2017, at the State House in Augusta, Maine.

US Health and Human Services Secretary Tom Price was visiting West Virginia on Tuesday for a “listening tour” to brainstorm solutions to the current opioid crisis when a reporter asked Price his thoughts on various drug treatment options, according to a report from the Charleston Gazette-Mail.

While Price echoed the Obama administration by calling substance-use disorder a “disease” and the crisis a “public health issue” and not a “criminal justice issue,” Price went against the prevailing wisdom on treatment options.

Price touted the success of faith-based treatment programs, and was decidedly non-supportive of medication-assisted treatment (MAT).

“If we’re just substituting one opioid for another, we’re not moving the dial much,” Price said of MAT, according to the Charleston Gazette-Mail. “Folks need to be cured so they can be productive members of society and realize their dreams.”

Considered by many experts to be the “gold standard” for overcoming opioid addiction, MAT uses prescription medications like buprenorphine or methadone to reduce cravings, allowing patients to work on the underlying issues leading to their substance use, without the constant pressure of withdrawal.

Studies in 2008 and 2011 conducted by the National Institute on Drug Abuse found that treatment using Suboxone, the most commonly prescribed version of buprenorphine, showed a “marked reduction” in drug use for participants. Approximately 50% of participants in the 2011 study reduced their substance use during extended Suboxone treatment. The success rate dropped to 8.6% once it was discontinued.

Because of its promising results, MAT has gained bipartisan support in statehouses, on Capitol Hill, and in scientific, medical, and treatment circles. But it’s expensive and remains difficult to access.

Bradley Stein, a senior natural scientist at the RAND Corporation who studies substance-use disorders, told Business Insider that MAT has “changed the landscape of treatment” for opioid-use disorder.

Stein said that states hit hard by the crisis like West Virginia and Pennsylvania have worked hard to expand access to MAT through public programs, Medicaid, and by expanding the number of physicians trained and certified to provide MAT.

West Virginia University is currently working to train primary care physicians throughout the state on how to administer medication-assisted treatment to expand desperately needed treatment across the state, Dr. Richard Vaglienti, the director of the Pain Management Center at West Virginia University told Business Insider earlier this year.

West Virginia had the highest drug-overdose death rate in the US with 41.5 deaths per 100,000 people in 2015.

Why Price’s opinion is important

Loading...
data-mce-source="REUTERS/Brian Snyder" src="https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_svHBIcuHwjJmD_KwB539bjXES3bqB23VBBflG6tFWG92hJ6V0fX1qyzYXkMxW0kEkGu_cr2zOu2Q=s0-d">

REUTERS/Brian Snyder

James Ingemi picks up Suboxone prescription as part of his treatment regimen for opiate dependency at the pharmacy at Boston Healthcare for the Homeless Program in Boston, Massachusetts January 14, 2013.

Secretary Price’s comments are extremely important because his opinions will shape the Trump administration’s approach to the opioid crisis.

With the American Health Care Act set to gut funding to Medicaid if passed, programs and policies implemented or championed by Price will take on increased relevance

During his last year in office, President Barack Obama signed two landmark laws — the Comprehensive Addiction and Recovery Act and the 21st Century Cares Act — that call for considerable funds for the opioid crisis. But how much and where those funds will go are hardly certain. Congress will continue to debate that in its budget negotiations.

It is not inconceivable to imagine Price recommending shifting funds allocated for MAT to faith-based treatments, if he thinks it is the best treatment option available.

Opioids, unlike many other substances, fundamentally change a person’s thought and behavior patterns.Almost all faith-based treatments are centered around achieving abstinence, but many addicts’ physical dependence on opioids makes abstinence incredibly difficult, if not impossible. Countless users relapse or skip out on treatment, no matter what stage of recovery they’re at.

MAT can be the difference between life or death for deeply entrenched opioid users, Turner Bitton, the president of the Drug Policy Project of Utah (DPP), told Business Insider. Those who fail out of abstinence-based treatment can go into a deep spiral of continuing use. Bitton is working to improve MAT access in Utah.

Trump established a commission headed by New Jersey Gov. Chris Christie in March to come up with solutions to the opioid crisis. The commission is set to submit a report by the end of the year.

NOW WATCH: Watch Sally Yates go toe to toe with Ted Cruz over Trump’s immigration ban

Please enable Javascript to watch this video

Read more stories on Business Insider, Malaysian edition of the world’s fastest-growing business and technology news website.



✍ Sumber Pautan : ☕ Business InsiderBusiness Insider

Kredit kepada pemilik laman asal dan sekira berminat untuk meneruskan bacaan sila klik link atau copy paste ke web server : http://ift.tt/2qsDfuh

(✿◠‿◠)✌ Mukah Pages : Pautan Viral Media Sensasi Tanpa Henti. Memuat-naik beraneka jenis artikel menarik setiap detik tanpa henti dari pelbagai sumber. Selamat membaca dan jangan lupa untuk 👍 Like & 💕 Share di media sosial anda!



dengan itu Perkara Trump’s health secretary isn’t a fan of the ‘gold standard’ substance-use treatment — bad news for the opioid crisis

yang semua artikel Trump’s health secretary isn’t a fan of the ‘gold standard’ substance-use treatment — bad news for the opioid crisis Kali ini, diharapkan dapat memberi manfaat kepada anda semua. Okay, jumpa di lain post artikel.

Kini anda membaca artikel Trump’s health secretary isn’t a fan of the ‘gold standard’ substance-use treatment — bad news for the opioid crisis dengan alamat pautan https://timesnewmalaysia.blogspot.com/2017/05/trumps-health-secretary-isnt-fan-of.html

Subscribe to receive free email updates:

Related Posts :

0 Response to "Trump’s health secretary isn’t a fan of the ‘gold standard’ substance-use treatment — bad news for the opioid crisis"

Catat Ulasan

Loading...